Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma

Zhengfei Zhu; Weiwei Yu; Xiaolong Fu; Menghong Sun; Qiao Wei; Dali Li; Haiquan Chen; Jiaqing Xiang; Hecheng Li; Yawei Zhang; Weixin Zhao; Kuaile Zhao
September 2015
Journal of Experimental & Clinical Cancer Research (17569966);9/4/2015, Vol. 34 Issue 1, p1
Academic Journal
Background: The epidermal growth factor receptor (EGFR) signaling pathway is important in regulating biological behaviors in many malignancies. We explored whether expression and activation of EGFR and several components on its downstream pathways have prognostic significance in patients with esophageal squamous cell carcinoma (ESCC). Methods: Expression of EGFR, phosphorylated (p)-EGFR, AKT1, p-AKT1, AKT2, p-AKT2, ERK1, ERK2, p-ERK1/2, STAT3, and p-STAT3 was assessed by immunohistochemical analysis of tissue microarrays for 275 ESCC patients who had undergone complete three-field lymphadenectomy. Spearman rank correlation tests were used to determine the relationships among protein expression, and Cox regression analyses were performed to determine the prognostic factors on overall survival (OS). Results: p-EGFR expression was correlated statistically with all of the other phosphorylated markers. Gender, N stage, and p-AKT1 expression were found to be independent prognostic factors for OS. Increased expression of p-AKT1 was associated with decreased patient survival. EGFR and p-EGFR expression was not significantly associated with patient survival. Conclusion: Activation of AKT1 was associated with poor prognosis in ESCC.


Related Articles

  • Genetic Variants in Epidermal Growth Factor Receptor Pathway Genes and Risk of Esophageal Squamous Cell Carcinoma and Gastric Cancer in a Chinese Population. Li, Wen-Qing; Hu, Nan; Wang, Zhaoming; Yu, Kai; Su, Hua; Wang, Lemin; Wang, Chaoyu; Chanock, Stephen J.; Burdett, Laurie; Ding, Ti; Qiao, You-Lin; Fan, Jin-Hu; Wang, Yuan; Xu, Yi; Giffen, Carol; Xiong, Xiaoqin; Murphy, Gwen; Tucker, Margaret A.; Dawsey, Sanford M.; Freedman, Neal D. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The epidermal growth factor receptor (EGFR) signaling pathway regulates cell proliferation, differentiation, and survival, and is frequently dysregulated in esophageal and gastric cancers. Few studies have comprehensively examined the association between germline genetic variants in the EGFR...

  • Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC). Chi Hang Wong; Buig Yue Ma, Brigette; Wun Chun Hui, Connie; Qian Tao; Tak Cheung Chan, Anthony // American Journal of Cancer Research;2015, Vol. 5 Issue 12, p3588 

    Esophageal squamous cell carcinoma (ESCC) is the eighth most common cancer worldwide. Epidermal growth factor receptors (EGFR) are often overexpressed in esophageal cancers, thus anti-EGFR inhibitors have been evaluated in ESCC. Afatinib was an irreversible inhibitor of these ErbB family...

  • A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis. Cao, Hui-Hui; Zheng, Chun-Peng; Wang, Shao-Hong; Wu, Jian-Yi; Shen, Jin-Hui; Xu, Xiu-E; Fu, Jun-Hui; Wu, Zhi-Yong; Li, En-Min; Xu, Li-Yan // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Background: Esophageal squamous cell carcinoma (ESCC) has the highest mortality rates in China. The 5-year survival rate of ESCC remains dismal despite improvements in treatments such as surgical resection and adjuvant chemoradiation, and current clinical staging approaches are limited in their...

  • Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy. Torka, Robert; Pénzes, Kinga; Gusenbauer, Simone; Baumann, Christine; Szabadkai, István; Őrfi, Lászlȯ; Kéri, György; Ullrich, Axel // Neoplasia;Apr2014, Vol. 16 Issue 4, p301 

    The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer. However, the benefits of targeted therapies are limited due to acquired resistance and activation of alternative RTKs. Therefore, we asked if cancer cells are able to overcome...

  • PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells. Xie, Z; Jiang, Y; Liao, E-Y; Chen, Y; Pennypacker, S D; Peng, J; Chang, S M // Oncogene;12/6/2012, Vol. 31 Issue 49, p5090 

    One of the key drivers for squamous cell carcinoma (SCC) proliferation is activation of the epidermal growth factor receptor (EGFR), a known proto-oncogene. However, the mechanism of EGFR-dependent SCC proliferation remains unclear. Our previous studies indicate that epidermal growth factor...

  • Esophageal Cancer and the Importance of Epidermal Growth Factor (EGFR). Anvari, Kazem; Anvari, Azam; Toosi, Mehdi Silanian // Reviews in Clinical Medicine;2014, Vol. 1 Issue 2, p7 

    Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies, worldwide. It is important to find out what prognostic factors can facilitate diagnosis, optimize therapeutic decisions, and improve the survival of these patients. Despite improvements in surgical techniques...

  • The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells. Yang, Pei-Wen; Hung, Mien-Chie; Hsieh, Ching-Yueh; Tung, En-Chi; Wang, Ying-Hao; Tsai, Jui-Chang; Lee, Jang-Ming // Lasers in Medical Science;Feb2013, Vol. 28 Issue 2, p605 

    Photodynamic therapy (PDT) has been demonstrated to be an effective minimally invasive treatment modality for early esophageal cancer. However, the molecular action in esophageal cancer during PDT is hardly known. EGFR has been known to downregulate in various cancer cells during PDT. In this...

  • G-protein-coupled receptor kinases in inflammation and disease. Packiriswamy, N; Parameswaran, N // Genes & Immunity;Sep2015, Vol. 16 Issue 6, p367 

    G-protein-coupled receptor kinases (GRKs) are serine/threonine protein kinases originally discovered for their role in G-protein-coupled receptor (GPCR) phosphorylation. Recent studies have demonstrated a much broader function for this kinase family including phosphorylation of cytosolic...

  • Human 14-3-3 Paralogs Differences Uncovered by Cross-Talk of Phosphorylation and Lysine Acetylation. Uhart, Marina; Bustos, Diego M. // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    The 14-3-3 protein family interacts with more than 700 different proteins in mammals, in part as a result of its specific phospho-serine/phospho-threonine binding activity. Upon binding to 14-3-3, the stability, subcellular localization and/or catalytic activity of the ligands are modified....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics